<i>In Vivo</i> Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities

Elisa ten Hacken(Harvard University), Catherine J. Wu(Dana-Farber Cancer Institute), Alanna Sholokhova(University of Washington), Donna Neuberg(Otsuka (Japan)), Giorgio Inghirami(Cornell University), Julien Broséus(Inserm), Fabienne Lucas(Brigham and Women's Hospital), Robert Redd(Harvard University), Kendell Clement(Broad Institute), Tomasz Sewastianik(Harvard University), Stephan Stilgenbauer(Universität Ulm), Tiziana Vaisitti(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Geoffrey Fell(Dana-Farber Cancer Institute), Eugen Tausch(Universität Ulm), Romain Guièze(Broad Institute), Ruben D. Carrasco(Brigham and Women's Hospital), Heather Joyal(Dana-Farber Cancer Institute), Elizabeth Witten(Dana-Farber Cancer Institute), Leah Billington(Dana-Farber Cancer Institute), Livius Penter(Dana-Farber Cancer Institute), Erin M. Parry(Broad Institute), María Hernández‐Sánchez(Universidad de Salamanca), Ivana Božić(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Kenneth J. Livak(Broad Institute), Binyamin A. Knisbacher(Broad Institute), Kaitlyn Baranowski(Dana-Farber Cancer Institute), Matthew S. Davids(Dana-Farber Cancer Institute), Pierre Feugier(Inserm), Silvia Deaglio(Department of Medical Sciences), Shanye Yin(Albert Einstein College of Medicine), Haoxiang Lyu(Dana-Farber Cancer Institute), Michaela Gruber(Dana-Farber Cancer Institute), Sébastien Hergalant(Inserm), Fara Faye Regis(Dana-Farber Cancer Institute), Jackson Southard(Dana-Farber Cancer Institute), Mohamed Uduman(Dana-Farber Cancer Institute), Gabriela Brunsting Hoffmann(Dana-Farber Cancer Institute), Shuqiang Li(Dana-Farber Cancer Institute), Neil Ruthen(Dana-Farber Cancer Institute), Gad Getz(Broad Institute)
Blood Cancer Discovery
December 5, 2022
Cited by 27


Related Papers